These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2353173)
1. Role of rectal formulations: enemas. Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Petronelli A; Miglioli M; Barbara L Scand J Gastroenterol Suppl; 1990; 172():63-5. PubMed ID: 2353173 [TBL] [Abstract][Full Text] [Related]
2. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis. Mantzaris GJ; Hatzis A; Petraki K; Spiliadi C; Triantaphyllou G Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749 [TBL] [Abstract][Full Text] [Related]
3. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Lee FI; Jewell DP; Mani V; Keighley MR; Kingston RD; Record CO; Grace RH; Daniels S; Patterson J; Smith K Gut; 1996 Feb; 38(2):229-33. PubMed ID: 8801202 [TBL] [Abstract][Full Text] [Related]
4. Distribution of mesalazine enemas in active and quiescent ulcerative colitis. van Bodegraven AA; Boer RO; Lourens J; Tuynman HA; Sindram JW Aliment Pharmacol Ther; 1996 Jun; 10(3):327-32. PubMed ID: 8791959 [TBL] [Abstract][Full Text] [Related]
5. Availability of mesalazine (5-aminosalicylic acid) from enemas and suppositories during steady-state conditions. Jacobsen BA; Abildgaard K; Rasmussen HH; Christensen LA; Fallingborg J; Hansen SH; Rasmussen SN Scand J Gastroenterol; 1991 Apr; 26(4):374-8. PubMed ID: 2034991 [TBL] [Abstract][Full Text] [Related]
6. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Schroeder KW Scand J Gastroenterol Suppl; 2002; (236):42-7. PubMed ID: 12408503 [TBL] [Abstract][Full Text] [Related]
7. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Miglioli M; Barbara L J Clin Gastroenterol; 1988 Aug; 10(4):406-9. PubMed ID: 3418088 [TBL] [Abstract][Full Text] [Related]
8. Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. Brogden RN; Sorkin EM Drugs; 1989 Oct; 38(4):500-23. PubMed ID: 2684592 [TBL] [Abstract][Full Text] [Related]
10. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075 [TBL] [Abstract][Full Text] [Related]
11. Is topical therapy necessary in acute distal colitis? Double-blind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis. Cobden I; al-Mardini H; Zaitoun A; Record CO Aliment Pharmacol Ther; 1991 Oct; 5(5):513-22. PubMed ID: 1793782 [TBL] [Abstract][Full Text] [Related]
12. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
13. Distribution of mesalamine enemas in patients with active distal ulcerative colitis. Chapman NJ; Brown ML; Phillips SF; Tremaine WJ; Schroeder KW; Dewanjee MK; Zinsmeister AR Mayo Clin Proc; 1992 Mar; 67(3):245-8. PubMed ID: 1545592 [TBL] [Abstract][Full Text] [Related]
14. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. Barber GB; Lee DE; Antonioli DA; Peppercorn MA Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789 [TBL] [Abstract][Full Text] [Related]
15. A practical guide to the management of distal ulcerative colitis. Ardizzone S; Bianchi Porro G Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342 [TBL] [Abstract][Full Text] [Related]
16. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Sutherland LR; Martin F; Greer S; Robinson M; Greenberger N; Saibil F; Martin T; Sparr J; Prokipchuk E; Borgen L Gastroenterology; 1987 Jun; 92(6):1894-8. PubMed ID: 3569765 [TBL] [Abstract][Full Text] [Related]
17. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results. Guarino J; Chatzinoff M; Berk T; Friedman LS Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786 [TBL] [Abstract][Full Text] [Related]
18. Role of rectal formulations: suppositories. Williams CN Scand J Gastroenterol Suppl; 1990; 172():60-2. PubMed ID: 2191425 [TBL] [Abstract][Full Text] [Related]
19. A mesalazine enema for ulcerative colitis. Drug Ther Bull; 1994 May; 32(5):38-9. PubMed ID: 7635028 [TBL] [Abstract][Full Text] [Related]
20. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis. d'Albasio G; Trallori G; Ghetti A; Milla M; Nucci A; Pacini F; Morettini A Dis Colon Rectum; 1990 May; 33(5):394-7. PubMed ID: 1970284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]